← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 10, 2017Last known activity
Nov 22, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Recent trials (6)
- NCT05070468Study directorPhase 3Nov 22, 2020
- NCT05070468Reponsible party - principal investigatorPhase 3Nov 22, 2020
- NCT05070468Lead sponsorPhase 3Nov 22, 2020
- NCT03795974Study directorPhase 2Jul 23, 2017
- NCT03193944Lead sponsorPhase 2Feb 10, 2017
- NCT03193944Reponsible party - principal investigatorPhase 2Feb 10, 2017
Details
- Last known activity
- Nov 22, 2020